Evaxion Biotech A/S financial data

Symbol
EVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Dr Neergaards Vej 5 F, Hoersholm, Denmark
State of incorporation
Denmark
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Apr 1, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.1M shares +85.1%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 2.75M USD -6.27%
General And Administrative Expense 1.98M USD -27.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 12.5M USD -3.13%
Liabilities 14.1M USD -19.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Interest Expense 185K USD +4.52%